New drug trial aims to stop body from rejecting transplanted lungs
NCT ID NCT06033196
Summary
This study is testing if adding a drug called tocilizumab to standard anti-rejection medications can better protect transplanted lungs. It will involve 350 recent lung transplant recipients, who will receive either tocilizumab or a placebo for about 20 weeks. The main goal is to see if this combination reduces the risk of the transplanted lungs failing, needing a second transplant, or death over three years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barnes Jewish Hospital/ Washington University SOM (Site #: 71191)
RECRUITINGSt Louis, Missouri, 63110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Boston Children's Hospital and Harvard Medical School (Site #: 71001)
WITHDRAWNBoston, Massachusetts, 02215, United States
-
Cedars Sinai Medical Center (Site #: 71146)
RECRUITINGBeverly Hills, California, 90211, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cleveland Clinic (Site #: 71101)
RECRUITINGCleveland, Ohio, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Columbia University Medical Center (Site #: 71113)
RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
David Geffen School of Medicine at UCLA (Site #: 71123)
RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Duke University Medical Center (Site #: 71139)
RECRUITINGDurham, North Carolina, 27710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Emory University (Site #: 71103)
NOT_YET_RECRUITINGAtlanta, Georgia, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Houston Methodist Hospital (Site #: 71120)
WITHDRAWNHouston, Texas, 77030, United States
-
Massachusetts General Hospital (Site #: 71107)
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mayo Clinic Rochester (Site #: 71160)
NOT_YET_RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ohio State University Medical Center (Site #: 71196)
NOT_YET_RECRUITINGColumbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Joseph's Hospital and Medical Center (Site #: 71192)
RECRUITINGPhoenix, Arizona, 85013, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Louis Children's Hospital of Washington University (Site #: 71006)
WITHDRAWNSt Louis, Missouri, 63110, United States
-
Temple University (Site #: 71197)
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19140, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Florida Shands Hospital (Site #: 71131)
NOT_YET_RECRUITINGGainesville, Florida, 32610, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Maryland Medical Center (Site #: 71138)
WITHDRAWNBaltimore, Maryland, 21201, United States
-
University of Texas Health Science at San Antonio (Site #: 71198)
NOT_YET_RECRUITINGSan Antonio, Texas, 78229, United States
Contact Email: •••••@•••••
-
University of Texas Southwestern (Site #: 71187)
RECRUITINGDallas, Texas, 75390, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Utah Medical Center (Site #: 71126)
RECRUITINGSalt Lake City, Utah, 84132, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.